Cite
MLA Citation
M. Untch et al.. “1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44).” European journal of cancer, vol. 51, n.d., pp. S264–. http://access.bl.uk/ark:/81055/vdc_100030628126.0x000037